Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-04

Clinical Trial Update: Influence of the Proton Pump Inhibitor Omeprazole on the Anti-Platelet of P2Y12 Antagonists in Subjects With Coronary and Peripheral Artery Disease

View source ↗

Summary

A completed trial investigated whether the proton pump inhibitor omeprazole affects the antiplatelet action of P2Y12 antagonists in subjects with coronary arter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omeprazole (Omeprazole)

Snippet

Sponsor: University of Oklahoma | Conditions: Coronary Artery Disease, Peripheral Artery Disease | Status: COMPLETED